TABLE 4.

Median inhibitory and bactericidal titers in serum of gatifloxacin and moxifloxacin over time against anaerobic bacteria^a

Organism and time point (h)	Gatifloxacin		Moxifloxacin
	SIT (range)	SBT (range)	SIT (range)	SBT (range)
F. nucleatum
2	1:4 (<1:2-1:16)	1:4 (1:2-1:16)	1:4 (1:4-1:32)	1:4 (1:4-1:32)
6	1:2 (<1:2-1:4)	1:2 (1:2-1:4)	1:4 (1:2-1:8)	1:4 (1:2-1:8)
12	1:2 (<1:2-1:4)	1:2 (<1:2-1:4)	1:2 (1:2-1:4)	1:2 (1:2-1:4)
24	<1:2 (<1:2-1:4)	<1:2 (<1:2-1:4)	1:2 (<1:2-1:2)	1:2 (<1:2-1:2)
P. melaninogenica
2	1:8 (1:4-1:16)	1:4 (1:4-1:8)	1:4 (1:2-1:8)	1:4 (<1:2-1:8)
6	1:4 (1:2-1:8)	1:4 (1:2-1:8)	1:4 (1:4-1:8)	1:4 (<1:2-1:4)
12	1:4 (1:2-1:8)	1:4 (1:2-1:8)	1:4 (1:2-1:4)	1:2 (1:2-1:4)
24	1:2 (<1:2-1:4)	1:2 (<1:2-1:4)	1:2 (<1:2-1:4)	1:2 (<1:2-1:4)
P. micros
2	1:8 (1:8->1:32)	1:8 (1:8-1:16)	1:16 (1:8-1:16)	1:16 (1:8-1:16)
6	1:8 (1:2-1:16)	1:4 (1:2-1:8)	1:8 (1:4-1:16)	1:8 (1:4-1:8)
12	1:4 (1:2-1:8)	1:4 (1:2-1:4)	1:4 (1:2-1:16)	1:4 (<1:2-1:8)
24	1:2 (<1:2-1:2)	<1:2 (<1:2-1:2)	1:2 (1:2-1:4)	1:2 (<1:2-1:4)
P. magnus
2	1:8 (1:8-1:32)	1:8 (1:4-1:32)	1:32 (1:16-1:32)	1:16 (1:16-1:32)
6	1:8 (1:4-1:16)	1:8 (1:2-1:16)	1:16 (1:8-1:32)	1:8 (1:8-1:32)
12	1:4 (1:2-1:8)	1:4 (1:2-1:4)	1:8 (1:4-1:8)	1:8 (1:4-1:8)
24	1:2 (1:2)	1:2 (<1:2-1:2)	1:4 (1:2-1:8)	1:4 (1:2-1:4)

^aSIT, serum inhibitory titer, SBT, serum bactericidal titer.